Clinical trial to investigate causes of diabetes, obesity in individuals with spinal cord injury and potential mitigatory effects of semaglutide

September 4, 2024

A first-of-its-kind investigation into the mechanisms behind diabetes and obesity in people with spinal cord injury and the antidiabetic and anti-obesity effects of semaglutide was recently approved for $3 million in National Institutes of Health funding. “This is one population in which they are susceptible to be more obese and having worse diabetes risk and […]


Personal challenge to global solution

September 4, 2024

UT Health San Antonio urologist demonstrates potential of valproic acid-DHA in lessening risk of contracting COVID-19   When the world locked down due to the COVID-19 pandemic in 2020, rather than slowing down, this distinguished urologist and medical educator merely switched gears.   Ronald Rodriguez, MD, PhD, is a professor of medical education and urology at Joe […]